Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-01 Coulie Bernard President and CEO Sale −105 $35.55 $4K 240,112
2023-02-01 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −15,000 357,262
2023-01-31 Coulie Bernard President and CEO Exercise or conversion +10,539 $2.08 $22K 250,651
2023-01-31 Coulie Bernard President and CEO Exercise or conversion +4,461 $6.22 $28K 255,112
2023-01-31 Coulie Bernard President and CEO Sale −15,000 $34.92 $524K 240,112
2023-01-31 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −10,539 146,841
2023-01-31 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −4,461 372,262
2023-01-30 Coulie Bernard President and CEO Exercise or conversion +15,000 $2.08 $31K 255,112
2023-01-30 Coulie Bernard President and CEO Sale −11,395 $33.98 $387K 243,717
2023-01-30 Coulie Bernard President and CEO Sale −3,605 $34.66 $125K 240,112
2023-01-30 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −15,000 157,380
2023-01-27 Coulie Bernard President and CEO Exercise or conversion +15,000 $2.08 $31K 255,112
2023-01-27 Coulie Bernard President and CEO Sale −8,698 $35.42 $308K 246,414
2023-01-27 Coulie Bernard President and CEO Sale −6,302 $36.06 $227K 240,112
2023-01-27 Coulie Bernard President and CEO Sale −9,779 $35.09 $343K 409,538
2023-01-27 Coulie Bernard President and CEO Sale −221 $36.64 $8K 409,317
2023-01-26 Coulie Bernard President and CEO Exercise or conversion +15,000 $2.08 $31K 255,112
2023-01-26 Coulie Bernard President and CEO Sale −15,000 $35.29 $529K 240,112
2023-01-26 Coulie Bernard President and CEO Sale −15,000 $35.10 $526K 419,317
2023-01-26 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −15,000 187,380

Page 10 of 19 · 379 trades